Brian Mehling, MD slated to participate in the 19th Annual World Congress of Society for Brain Mapping and Therapeutics
Breaking Boundaries of Science, Technology, Medicine, Art, and Healthcare Policy meeting being held in LA March 10-13 Brian Mehling, MD, founder and chief medical officer of BHI Therapeutic Sciences, will virtually present on three topics at the 19th Annual World Congress of Society for Brain Mapping and Therapeutics. The meeting, entitled Breaking Boundaries of Science, Technology, Medicine, Art, and Healthcare Policy, will be held at the Los Angeles Convention Center, March 10-13. Dr. Mehling will speak on the following: Safety study of Cultured Wharton’s Jelly Mesenchymal Stem...
Read MoreBHI CEO Participates in Patient Safety Workshop Sponsored by the Joint Commission
Doreen Santora, RN, MHA Doreen Santora, RN, MHA, chief executive officer of Blue Horizon International (BHI) and its subsidiaries, including BHI Therapeutic Sciences, recently participated the Joint Commission International (JCI) program titled Managing Patient Safety Events: A Root Cause Analysis Workshop. The two-day, live virtual workshop provided participants with the knowledge, skills, and strategies to establish a standardized approach to managing patient safety events, including sentinel events. “BHI Therapeutic Sciences is committed to providing the highest quality and...
Read MoreBRIAN MEHLING, MD EARNS ANTI-AGING AND REGENERATIVE MEDICINE BOARD CERTIFICATION
Brian Mehling, MD has successfully completed all components of the Board Certification in the field of Anti-Aging and Regenerative Medicine.Dr. Mehling is the founder and chief medical officer of Mehling Orthopedics and BHI Therapeutic Sciences (BHITS). He is a practicing American orthopedic trauma surgeon, researcher, and philanthropist. He spearheads groundbreaking research in stem cell therapy. Notably, BHITS is currently engaged in an FDA Investigational New Drug trial for stroke, using human umbilical cord blood (hUCB) stem cells.“Cellular medicine is in high demand and stem cells...
Read MoreBrian Mehling, M.D., and team travel to Monaco for potential investors
Brian Mehling, M.D., M.S.founder and chief medical officer of Blue Horizon International (BHI) and his team traveled to Monaco and Paris, France in November 2021, attending a series of meetings with potential investors and partners to expand access to stem cell therapeutics. #BlueHorizonStemCells #StemCellTherapy #Monaco...
Read MoreBrian Mehling, M.D. and his team attended the Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) at the San Diego Convention Center
Brian Mehling, M.D. and his team attended the Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) at the San Diego Convention Center, CA from August 31- September 3, 2021.AAOS is the world’s largest meeting of orthopaedic surgeons, researchers, and allied health professionals.Dr. Mehling is the chief medical officer at BHI Therapeutic Sciences, LLC, a company that offers a novel method of arthritis therapy using a patient’s own stromal vascular fraction (SVF) cells including mesenchymal stem cells.BHI Therapeutic Sciences exhibited at the conference data...
Read MoreChelsea Film Festival
Brian Mehling, M.D. hosted a gathering for filmmakers during the Chelsea Film Festival at his home in New York City on Friday October 15, 2021.Dr. Mehling is also a documentary film producer. He is president and CEO of Industrial Motion Pictures (IMP), producer of the film Tiny Tears, which debuted at the prestigious Cannes Film Festival. Their newest film, titled “Stem Cells: The Revolution Is Here” was part of the Chelsea Film Festival this year. DrBrianMehling #BlueHorizonStemCells ChelseaFilmFestival...
Read More
